Endomedix partnered with a catalyst with extensive experience in the hemostatic sealant market place at the tTAp. See Endomedics in action at the tTAp
– Endomedix selected as NIH featured at Bio 2015
– Endomedix receives a $1.5 M NIH Grant
Providing a less expensive sealant and hemostat for use during surgical procedures. Seeking to be used particularly for neuro applications.
- Technology Presenter: Richard Russo
- Commercial Catalysts: Meg Helms, Morgan Wallace